Literature DB >> 2039208

Comparison of the inoculum effects of members of the family Enterobacteriaceae on cefoxitin and other cephalosporins, beta-lactamase inhibitor combinations, and the penicillin-derived components of these combinations.

E J Goldstein1, D M Citron, C E Cherubin.   

Abstract

We compared the inoculum effects of 105 recent clinical isolates of the family Enterobacteriaceae on cefoxitin, other cephalosporins, aztreonam, and three beta-lactamase inhibitors (clavulanic acid, sulbactam, and tazobactam) and their penicillin-derived components. Piperacillin and aztreonam showed the largest inoculum effect, and cefoxitin showed the smallest. The other cephalosporins tested (cefotetan, ceftizoxime, and ceftriaxone) showed an intermediate inoculum effect. In general, the inoculum effect was of greater magnitude for the penicillin and beta-lactamase inhibitor combinations than for the cephalosporins tested. Bactericidal activity was assayed and morphologic changes were monitored for selected strains exhibiting a large inoculum effect. MICs correlated with bactericidal activity at an inoculum level of 10(5) CFU/ml, while activity at 10(8) CFU/ml was variable. Cefoxitin demonstrated the least filamentous transformation and the most rapid bactericidal activity. Aztreonam showed the most marked filamentous transformation and was no longer bactericidal at 10(8) CFU/ml. The beta-lactamase inhibitor combinations showed variable bactericidal activity, and regrowth occurred with a number of strains with all three agents tested.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2039208      PMCID: PMC245050          DOI: 10.1128/AAC.35.3.560

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  18 in total

1.  Relevance of the inoculum effect of antibiotics in the outcome of experimental infections caused by Escherichia coli.

Authors:  F Soriano; C Ponte; M Santamaría; M Jimenez-Arriero
Journal:  J Antimicrob Chemother       Date:  1990-04       Impact factor: 5.790

2.  Amoxycillin/clavulanate resistant Escherichia coli.

Authors:  G French; T Ling
Journal:  Lancet       Date:  1988-03-26       Impact factor: 79.321

3.  Staphylococcal beta-lactamase and efficacy of beta-lactam antibiotics: in vitro and in vivo evaluation.

Authors:  S W Chapman; R T Steigbigel
Journal:  J Infect Dis       Date:  1983-06       Impact factor: 5.226

4.  The beta-lactamase stability of a novel beta-lactam antibiotic containing a 7 alpha-methoxyoxacephem nucleus.

Authors:  M H Richmond
Journal:  J Antimicrob Chemother       Date:  1980-07       Impact factor: 5.790

5.  Interaction of azthreonam and related monobactams with beta-lactamases from gram-negative bacteria.

Authors:  K Bush; J S Freudenberger; R B Sykes
Journal:  Antimicrob Agents Chemother       Date:  1982-09       Impact factor: 5.191

6.  Variation in the potentiation of beta-lactam antibiotic activity by clavulanic acid and sulbactam against multiply antibiotic-resistant bacteria.

Authors:  K E Aldridge; C V Sanders; R L Marier
Journal:  J Antimicrob Chemother       Date:  1986-04       Impact factor: 5.790

7.  Inoculum effect of new beta-lactam antibiotics on Pseudomonas aeruginosa.

Authors:  R H Eng; S M Smith; C Cherubin
Journal:  Antimicrob Agents Chemother       Date:  1984-07       Impact factor: 5.191

8.  Effect of inoculum size on in vitro activity of norfloxacin against fecal anaerobic bacteria. Rationale for selective decontamination of the digestive tract.

Authors:  E J Goldstein; D M Citron; M L Corrado
Journal:  Am J Med       Date:  1987-06-26       Impact factor: 4.965

9.  Inoculum effect of beta-lactam antibiotics on Enterobacteriaceae.

Authors:  R H Eng; C Cherubin; S M Smith; F Buccini
Journal:  Antimicrob Agents Chemother       Date:  1985-11       Impact factor: 5.191

10.  Influence of inoculum size on activity of cefoperazone, cefotaxime, moxalactam, piperacillin, and N-formimidoyl thienamycin (MK0787) against Pseudomonas aeruginosa.

Authors:  M L Corrado; S H Landesman; C E Cherubin
Journal:  Antimicrob Agents Chemother       Date:  1980-12       Impact factor: 5.191

View more
  15 in total

1.  In vitro activities of the potent, broad-spectrum carbapenem MK-0826 (L-749,345) against broad-spectrum beta-lactamase-and extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli clinical isolates.

Authors:  J Kohler; K L Dorso; K Young; G G Hammond; H Rosen; H Kropp; L L Silver
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

2.  Effect of inoculum size on bacteriolytic activity of cefminox and four other beta-lactam antibiotics against Escherichia coli.

Authors:  F Soriano; R Edwards; D Greenwood
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

3.  Inoculum effect and bactericidal activity of cefditoren and other antibiotics against Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis.

Authors:  F Soriano; P Coronel; M Gimeno; M Jiménez; P García-Corbeira; R Fernández-Roblas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-09       Impact factor: 3.267

4.  Inoculum effect of β-lactam antibiotics.

Authors:  Justin R Lenhard; Zackery P Bulman
Journal:  J Antimicrob Chemother       Date:  2019-10-01       Impact factor: 5.790

5.  Inoculum effect on the efficacies of amoxicillin-clavulanate, piperacillin-tazobactam, and imipenem against extended-spectrum β-lactamase (ESBL)-producing and non-ESBL-producing Escherichia coli in an experimental murine sepsis model.

Authors:  F Docobo-Pérez; L López-Cerero; R López-Rojas; P Egea; J Domínguez-Herrera; J Rodríguez-Baño; A Pascual; J Pachón
Journal:  Antimicrob Agents Chemother       Date:  2013-02-25       Impact factor: 5.191

6.  Measurement of antimicrobial-resistant Escherichia coli in pig feces with a hydrophobic grid membrane filter interpreter system.

Authors:  R H Dunlop; S A McEwen; A H Meek; R C Clarke; R M Friendship; W D Black; A N Sharpe
Journal:  Appl Environ Microbiol       Date:  1998-01       Impact factor: 4.792

7.  Mechanism of suppression of piperacillin resistance in enterobacteria by tazobactam.

Authors:  T A Kadima; J H Weiner
Journal:  Antimicrob Agents Chemother       Date:  1997-10       Impact factor: 5.191

8.  Pharmacological study of cefoxitin as an alternative antibiotic therapy to carbapenems in treatment of urinary tract infections due to extended-spectrum-β-lactamase-producing Escherichia coli.

Authors:  H Guet-Revillet; A Emirian; M Groh; B Nebbad-Lechani; E Weiss; O Join-Lambert; E Bille; V Jullien; J R Zahar
Journal:  Antimicrob Agents Chemother       Date:  2014-04-28       Impact factor: 5.191

9.  Comparison of the inoculum effect of cefoxitin and other cephalosporins and of beta-lactamase inhibitors and their penicillin-derived components on the Bacteroides fragilis group.

Authors:  E J Goldstein; D M Citron; C E Cherubin
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

Review 10.  Piperacillin/tazobactam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential.

Authors:  H M Bryson; R N Brogden
Journal:  Drugs       Date:  1994-03       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.